Doxapram Treatment and Diaphragmatic Activity in Preterm Infants

BACKGROUND: Doxapram is a treatment option for severe apnea of prematurity (AOP). However, the effect of doxapram on the diaphragm, the main respiratory muscle, is not known. OBJECTIVES: To investigate the effect of doxapram on diaphragmatic activity measured with transcutaneous electromyography of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neonatology
Auteurs principaux: de Waal, Cornelia G., Hutten, Gerard J., Kraaijenga, Juliette V., de Jongh, Frans H., van Kaam, Anton H.
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2019
Sujets:
Short Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425813/
https://ncbi.nlm.nih.gov/pubmed/30352445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493359
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires